Healthcare Pharmaceutical Biotech

Protagonist Therapeutics Reports Granting of Inducement Awards

August 4, 2026 4:05 PM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on July 31, 2026, it granted inducement awards to two recently hired employees in accordance with the terms of their employment offer letters. The awards were granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020 and February 15, 2022. The new employees received, in the aggregate, options to...

Read more

LevelsRx Reviews 2026: The Clinician-Guided GLP-1 Access Option Busy Adults May Wish They Found Sooner

August 4, 2026 1:30 PM

Quick disclosure before you dive in: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims come from the brand and aren't independently endorsed here. LevelsRx is a telehealth platform that connects patients with compounded GLP-1 medications - not a drug manufacturer, not a pharmacy, and not FDA-approved itself. A prescription takes a real consultation and sign-off from a licensed...

Read more

Brain Memory Keeper Reviews & Complaints 2026: The 7-Ingredient Mental-Sharpness Upgrade Adults May Wish They Found Sooner

August 4, 2026 1:15 PM

Quick disclosure: this is a paid advertorial, and this content is promotional in nature, written for consumer education about a commercially available product. A commission may be earned if a purchase is made through links here, at no additional cost to you. Product claims are attributed to the brand and are not independently endorsed. Brain Memory Keeper is a dietary supplement - not FDA-approved, not intended to diagnose, treat, cure, or...

Read more

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus

August 4, 2026 11:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that following Health Canada's authorization of the study, the first participants have been vaccinated in a Phase 1 clinical study in Canada evaluating mRNA-1469, the Company's investigational mRNA vaccine being evaluated to prevent Bundibugyo ebolavirus, or BDBV, disease. The vaccine candidate is being developed using Moderna's mRNA platform, the same technology that demonstrated rapid development,...

Read more

Isto Biologics Strengthens its Bone Graft Substitutes Platform with the Acquisition of NovaBone

August 4, 2026 10:40 AM

Isto Biologics ("Isto"), a biologics company dedicated to advancing bone healing, today announced the acquisition of NovaBone Products LLC ("NovaBone"), a developer and manufacturer of synthetic bone graft products, from Halma plc. Supported by Keensight Capital ("Keensight"), one of the leading private equity managers dedicated to pan-European Growth Buyout[1] investments, the acquisition adds a differentiated portfolio of bioactive glass...

Read more

Morpheus Medical Aesthetics Expands Advanced Skin Rejuvenation Services with Tixel Aesthetics

August 4, 2026 10:35 AM

Morpheus Medical Aesthetics, a premier Northern California medical spa known for its personalized approach to aesthetic medicine and exceptional patient care, today announced the addition of Tixel Aesthetics to its comprehensive portfolio of advanced aesthetic treatments. The introduction of Tixel Aesthetics reflects Morpheus Medical Aesthetics' ongoing commitment to providing patients with evidence-based treatment options focused on...

Read more

CVS Health Uses Career Development Programs To Build Its Future Workforce

August 4, 2026 10:30 AM

Originally published on CVS Health Company Newsroom As health care continues to evolve, employers are increasingly looking beyond recruitment to ensure they have the talent needed for the future. At CVS Health, workforce development has become a key strategy for preparing employees to take on new opportunities while helping the company meet changing business demands. CVS Health believes that investing in employee learning and career advancement...

Read more

Amazing Point of View Eye Care & Eye Gym Expands Care for Evaporative Dry Eye and Periocular Skin Concerns

August 4, 2026 10:10 AM

Amazing Point of View Eye Care & Eye Gym, a Texas optometry practice focused on personalized eye care and visual wellness, today announced the addition of Tixel for Dry Eye and Tixel for Youthful Eyes to its clinical services. The new treatment options expand the practice's support for patients experiencing evaporative dry eye while addressing common skin concerns in the delicate area surrounding the eyes. The expansion builds on the practice's...

Read more

Pharma Fusion Launches National Specialty Nursing Division with Acquisition of 25 Degree Nursing

August 4, 2026 10:00 AM

Pharma Fusion, a leading national specialty pharmacy serving patients with rare and complex conditions, today announced the acquisition of 25 Degree Nursing, a national provider of specialty nursing services supporting patients receiving complex infusion therapies. The acquisition establishes Pharma Fusion's national specialty nursing division and expands the company's ability to deliver fully integrated pharmacy and nursing services nationwide....

Read more

Health Care Administrators Association (HCAA) Appoints 2026-2027 Board of Directors

August 4, 2026 10:00 AM

The Health Care Administrators Association (HCAA), a leader in education, networking, resources, and advocacy for the self-funding industry, today announced its new Board of Directors and Officers serving for the 2026-2027 term. This group of executives will lead the association in its efforts to extend awareness of self-funding initiatives, promote educational forums, engage and grow membership levels, and direct advocacy efforts. HCAA...

Read more

Utah Medical Products, Inc. Announces Quarterly Dividend

August 4, 2026 10:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year. Utah Medical Products, Inc., with particular interest in health care for women and their...

Read more

TailorMed and RxSense Partner to Surface Manufacturer Copay Assistance Within Digital Pharmacy Marketplaces

August 4, 2026 9:00 AM

TailorMed, the leading medication success platform, and RxSense, a healthcare technology company delivering industry-leading pharmacy benefit solutions, today announced a partnership to expand how consumers discover prescription savings for brand-name medications through digital pharmacy marketplaces. Through the integration, TailorMed's affordability technology is embedded into participating RxSense-powered marketplace tools, enabling retail...

Read more

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval

August 4, 2026 9:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Dienogest tablets of 2mg for the Canadian market. Dienogest is the generic equivalent of the brand name, Visanne®. Dienogest works through progesterone receptor binding, local anti-inflammatory actions, and mild hormone suppression. It reduces...

Read more

Inspired Spine, Avicenna Hospital Spring, and Avicenna Technical University Complete Landmark Educational Mission Across India

August 4, 2026 8:45 AM

Inspired Spine, Avicenna Hospital Spring, and Avicenna Technical University (ATU) have successfully completed a landmark educational mission across India, bringing advanced minimally invasive spine surgery training to surgeons, residents, and medical students from throughout Asia and beyond. The multi-city program was conducted in collaboration with leading Indian academic institutions, including Rohilkhand Medical College and Hospital,...

Read more

DaVita Community Care Report 2025 : The Value of Community-Based Health Screenings

August 4, 2026 8:35 AM

DaVita Commitments in Action Community Partnerships for Health In 2025, DaVita expanded its work with the YMCA to support chronic kidney disease (CKD) education and prevention. Focused on promoting access to care for all, the collaboration brings free health screenings and culturally-attuned health education to cities nationwide. This year, DaVita's Community Health Experience brought no-cost kidney health screenings and education to Orlando,...

Read more

BioAdaptives Explains the Scientific Basis of the Dual-Action Xcellara(TM) "Supply and Direction" Platform

August 4, 2026 8:00 AM

A developer of natural, science-backed wellness solutions today explained the scientific basis for its Xcellara™ "Supply and Direction" product development platform. Traditional stem cell support products mainly aim to boost circulating stem cell levels in the blood. While this offers certain health benefits, it does not guide the mobilized cells to specific target areas. On the other hand, typical tissue support ingredients like joint collagen...

Read more

ESSE Care Hosts Second Annual Summer Soirée, Celebrating the Partnerships Advancing Endometriosis and Fertility Care

August 4, 2026 7:00 AM

ESSE Care hosted its second annual Summer Soirée on Thursday, July 23, welcoming physicians, healthcare professionals, referral partners, and wellness collaborators to the Shafer Clinic Sky Terrace for an evening celebrating the partnerships that are transforming multidisciplinary endometriosis and fertility care. Building on the success of its inaugural event in 2025, ESSE Care has made the Summer Soirée an annual tradition honoring the trusted...

Read more

Zomedica Launches the PulseVet Acoustic Muffler(TM) Accessory for PulseVet(R) Shock Wave System

August 4, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the PulseVet Acoustic Muffler, an innovative accessory designed to significantly reduce the acoustic noise associated with shock wave therapy treatments while preserving the clinical performance practitioners rely on. Developed...

Read more

From Bench to Breakthrough: Empowering the Next Generation of Science Communicators

August 4, 2026 5:35 AM

The 30th annual American Chemical Society Green Chemistry & Engineering Conference gathered educators, students, and industry professionals in San Antonio with a shared goal: advancing sustainability in chemistry and reducing the environmental impact of science. As a champion of both efforts, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, supported the conference as a sponsor, with experts...

Read more

Cantargia to Host Q2 2026 Interim Results Conference Call

August 4, 2026 4:20 AM

Cantargia AB (publ), "Cantargia" (STO:CANTA) will publish its interim report for January - June 2026 on Wednesday, August 19, 2026, at 07:00 a.m. CEST. Interested investors, analysts, and media are invited to Cantargia's quarterly conference call on the same date at 3:00 p.m. CEST. The event will be hosted by Cantargia's CEO Hilde Steineger and CFO Patrik Renblad. During the call, management will review the Company's interim financial results...

Read more